The concept of “ambulatory” and “non-ambulatory” in patients with Duchenne muscular dystrophy: definitions and criteria

Duchenne muscular dystrophy (DMD) is a fatal neuromuscular disease due to a mutation in the gene encoding dystrophin synthesis. In patients, muscle damage and atrophy progresses, the ability to move independently decreases as well as respiratory and cardiac functions. At various stages of the diseas...

Full description

Bibliographic Details
Main Authors: T. A. Gremyakova, S. V. Artemyeva, N. D. Vashakmadze, I. P. Vitkovskaya, V. I. Guzeva, O. V. Guzeva, L. M. Kuzenkova, S. V. Mikhailova, L. P. Nazarenko, T. M. Pervunina, N. L. Pechatnikova, T. V. Podkletnova, G. E. Sakbaeva, A. A. Stepanov, V. M. Suslov, O. I. Gremyakova, N. I. Shakhovskaya, S. S. Nikitin
Format: Article
Language:Russian
Published: ABV-press 2022-06-01
Series:Нервно-мышечные болезни
Subjects:
Online Access:https://nmb.abvpress.ru/jour/article/view/484
_version_ 1826558081768620032
author T. A. Gremyakova
S. V. Artemyeva
N. D. Vashakmadze
I. P. Vitkovskaya
V. I. Guzeva
O. V. Guzeva
L. M. Kuzenkova
S. V. Mikhailova
L. P. Nazarenko
T. M. Pervunina
N. L. Pechatnikova
T. V. Podkletnova
G. E. Sakbaeva
A. A. Stepanov
V. M. Suslov
O. I. Gremyakova
N. I. Shakhovskaya
S. S. Nikitin
author_facet T. A. Gremyakova
S. V. Artemyeva
N. D. Vashakmadze
I. P. Vitkovskaya
V. I. Guzeva
O. V. Guzeva
L. M. Kuzenkova
S. V. Mikhailova
L. P. Nazarenko
T. M. Pervunina
N. L. Pechatnikova
T. V. Podkletnova
G. E. Sakbaeva
A. A. Stepanov
V. M. Suslov
O. I. Gremyakova
N. I. Shakhovskaya
S. S. Nikitin
author_sort T. A. Gremyakova
collection DOAJ
description Duchenne muscular dystrophy (DMD) is a fatal neuromuscular disease due to a mutation in the gene encoding dystrophin synthesis. In patients, muscle damage and atrophy progresses, the ability to move independently decreases as well as respiratory and cardiac functions. At various stages of the disease, different methods of care and treatment of patients with DMD are used. The clinical effect of new methods of DMD target therapy may depend on the stage of development of the disease (ambulatory or non‑ambulatory). To date, there are no unified criteria for assessing the status of a patient in terms ambulatory. In clinical trials and real clinical practice, different approaches are used to assess the patient’s status. However, the conclusion about the functional capabilities is critical for patients with DMD as approaches in management of patients in ambulatory and non‑ambulatory stages differ significantly. This necessitates expert consensus to achieve consistency and avoid any of discrepancies on that issue.The paper reviews the available published data on the concepts of “ambulatory” and “non‑ambulatory” used in clinical trials, real clinical practice, international standards and recommendations. As a conclusion of this analysis, it is proposed in real clinical practice to interpret “ambulation” in DMD patients as ability to walk without the use of assistive devices and without specifying the distance and time, and “non‑ambulation” as condition in which the patient is forced to constantly use a wheelchair both indoors and outdoors.
first_indexed 2024-03-12T04:51:37Z
format Article
id doaj.art-2d5cb1f3844a45cb95295db2a3337785
institution Directory Open Access Journal
issn 2222-8721
2413-0443
language Russian
last_indexed 2025-03-14T08:38:49Z
publishDate 2022-06-01
publisher ABV-press
record_format Article
series Нервно-мышечные болезни
spelling doaj.art-2d5cb1f3844a45cb95295db2a33377852025-03-02T12:54:44ZrusABV-pressНервно-мышечные болезни2222-87212413-04432022-06-01122101810.17650/2222-8721-2022-12-2-10-18317The concept of “ambulatory” and “non-ambulatory” in patients with Duchenne muscular dystrophy: definitions and criteriaT. A. Gremyakova0S. V. Artemyeva1N. D. Vashakmadze2I. P. Vitkovskaya3V. I. Guzeva4O. V. Guzeva5L. M. Kuzenkova6S. V. Mikhailova7L. P. Nazarenko8T. M. Pervunina9N. L. Pechatnikova10T. V. Podkletnova11G. E. Sakbaeva12A. A. Stepanov13V. M. Suslov14O. I. Gremyakova15N. I. Shakhovskaya16S. S. Nikitin17Charitable Foundation “Gordey”Yu. E. Veltishchev Research Clinical Institute of PediatricsCentral Clinical Hospital of the Russian Academy of SciencesMorozov Children’s City Clinical Hospital of the Department of Health of the City of MoscowSaint Petersburg State Pediatric Medical UniversitySaint Petersburg State Pediatric Medical UniversityNational Medical Research Center for Children’s HealthRussian Children’s Clinical HospitalResearch Institute of Medical GeneticsInstitute of Perinatology and PediatricsMorozov Children’s City Clinical Hospital of the Department of Health of the City of MoscowNational Medical Research Center for Children’s HealthCentral Clinical Hospital with a Polyclinic of the President AdministrationCentral Clinical Hospital with a Polyclinic of the President AdministrationSaint Petersburg State Pediatric Medical UniversityCharitable Foundation “GordeyPsycho-neurological Hospital for Children with CNS Lesions with Mental DisordersResearch Centre for Medical GeneticsDuchenne muscular dystrophy (DMD) is a fatal neuromuscular disease due to a mutation in the gene encoding dystrophin synthesis. In patients, muscle damage and atrophy progresses, the ability to move independently decreases as well as respiratory and cardiac functions. At various stages of the disease, different methods of care and treatment of patients with DMD are used. The clinical effect of new methods of DMD target therapy may depend on the stage of development of the disease (ambulatory or non‑ambulatory). To date, there are no unified criteria for assessing the status of a patient in terms ambulatory. In clinical trials and real clinical practice, different approaches are used to assess the patient’s status. However, the conclusion about the functional capabilities is critical for patients with DMD as approaches in management of patients in ambulatory and non‑ambulatory stages differ significantly. This necessitates expert consensus to achieve consistency and avoid any of discrepancies on that issue.The paper reviews the available published data on the concepts of “ambulatory” and “non‑ambulatory” used in clinical trials, real clinical practice, international standards and recommendations. As a conclusion of this analysis, it is proposed in real clinical practice to interpret “ambulation” in DMD patients as ability to walk without the use of assistive devices and without specifying the distance and time, and “non‑ambulation” as condition in which the patient is forced to constantly use a wheelchair both indoors and outdoors.https://nmb.abvpress.ru/jour/article/view/484duchenne muscular dystrophyambulatorynonambulatoryrecommendationsclinical researchregulatory documentsdystrophinconsensus
spellingShingle T. A. Gremyakova
S. V. Artemyeva
N. D. Vashakmadze
I. P. Vitkovskaya
V. I. Guzeva
O. V. Guzeva
L. M. Kuzenkova
S. V. Mikhailova
L. P. Nazarenko
T. M. Pervunina
N. L. Pechatnikova
T. V. Podkletnova
G. E. Sakbaeva
A. A. Stepanov
V. M. Suslov
O. I. Gremyakova
N. I. Shakhovskaya
S. S. Nikitin
The concept of “ambulatory” and “non-ambulatory” in patients with Duchenne muscular dystrophy: definitions and criteria
Нервно-мышечные болезни
duchenne muscular dystrophy
ambulatory
nonambulatory
recommendations
clinical research
regulatory documents
dystrophin
consensus
title The concept of “ambulatory” and “non-ambulatory” in patients with Duchenne muscular dystrophy: definitions and criteria
title_full The concept of “ambulatory” and “non-ambulatory” in patients with Duchenne muscular dystrophy: definitions and criteria
title_fullStr The concept of “ambulatory” and “non-ambulatory” in patients with Duchenne muscular dystrophy: definitions and criteria
title_full_unstemmed The concept of “ambulatory” and “non-ambulatory” in patients with Duchenne muscular dystrophy: definitions and criteria
title_short The concept of “ambulatory” and “non-ambulatory” in patients with Duchenne muscular dystrophy: definitions and criteria
title_sort concept of ambulatory and non ambulatory in patients with duchenne muscular dystrophy definitions and criteria
topic duchenne muscular dystrophy
ambulatory
nonambulatory
recommendations
clinical research
regulatory documents
dystrophin
consensus
url https://nmb.abvpress.ru/jour/article/view/484
work_keys_str_mv AT tagremyakova theconceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT svartemyeva theconceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT ndvashakmadze theconceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT ipvitkovskaya theconceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT viguzeva theconceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT ovguzeva theconceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT lmkuzenkova theconceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT svmikhailova theconceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT lpnazarenko theconceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT tmpervunina theconceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT nlpechatnikova theconceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT tvpodkletnova theconceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT gesakbaeva theconceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT aastepanov theconceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT vmsuslov theconceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT oigremyakova theconceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT nishakhovskaya theconceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT ssnikitin theconceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT tagremyakova conceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT svartemyeva conceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT ndvashakmadze conceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT ipvitkovskaya conceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT viguzeva conceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT ovguzeva conceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT lmkuzenkova conceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT svmikhailova conceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT lpnazarenko conceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT tmpervunina conceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT nlpechatnikova conceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT tvpodkletnova conceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT gesakbaeva conceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT aastepanov conceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT vmsuslov conceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT oigremyakova conceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT nishakhovskaya conceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria
AT ssnikitin conceptofambulatoryandnonambulatoryinpatientswithduchennemusculardystrophydefinitionsandcriteria